Regenerative Medicine Market to Reach $49.9 Billion by 2027

Strategic Insights -

The global regenerative medicine market size was estimated at $16.69 billion in 2021 and is projected to grow at a CAGR of 20.03% to reach $49.94 billion by 2027. The market is expected to be driven by increasing adoption of stem cell technologies, gene therapies, and tissue engineering, as well as technological advancements in regenerative medicine biologics, 3D bioprinting, and biomaterials. The market is also expected to be influenced by the cumulative impact of COVID-19 and the ongoing conflict between Russia and Ukraine.

Key Takeaways:

  • The regenerative medicine market is expected to reach $49.9 billion by 2027, growing at a CAGR of 20.03% from 2021 to 2027.
  • The market is driven by increasing adoption of stem cell technologies, gene therapies, and tissue engineering, as well as technological advancements in regenerative medicine biologics, 3D bioprinting, and biomaterials.
  • The cumulative impact of COVID-19 is expected to have a significant impact on the market, with a potential negative impact on the world economy, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States.
  • The regenerative medicine market is expected to be influenced by regulatory issues, high costs associated with treatment, and the involvement of private players and academic institutes in research and development.
  • Companies such as Allergan plc, Amgen Inc., Gilead Sciences, Inc., Integra LifeSciences Holdings Corporation, Medtronic Plc, Mimedx Group, Novartis AG, Organogenesis Inc., Osiris Therapeutics, Inc., Smith & Nephew plc, Stryker Corporation, Takeda Pharmaceutical Co. Ltd., Vericel Corporation, Wright Medical Group N.V., and Zimmer Biomet Holdings Inc. are expected to play a significant role in the market.

Statistics:

  • The regenerative medicine market size was estimated at $16.69 billion in 2021.
  • The market is expected to reach $49.94 billion by 2027, growing at a CAGR of 20.03% from 2021 to 2027.
  • The cumulative impact of COVID-19 is expected to have a negative impact on the world economy, with especially long-term harsh effects on Russia.

Sources:

  • "Regenerative Medicine Market Research Report by Type, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19"
  • ResearchAndMarkets.com - "Regenerative Medicine Market Research Report by Type, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19"
  • M2 PressWIRE - "The Worldwide Regenerative Medicine Industry is Expected to Reach $49.9 Billion by 2027"